Reversibility of gastric mucosal lesions induced by sodium phosphate tablets and characterized by probe-based confocal laser endomicroscopy

Background and study aims: Adequate bowel preparation is key for the optimal quality of colonoscopy. The sodium phosphate laxatives used for preparation may induce gastric injuries. However, in vivo studies monitoring the effects of sodium phosphate on the gastric mucosa are currently lacking. We aimed to characterize the effects of sodium phosphate tablets (Colokit®; Mayoly Spindler, Chatou, France) on the gastric mucosa in a large-animal model.

Methods: Fourteen anesthetized pigs were used for this study. Fundic mucosal sites were analyzed at 1.5, 24, and 72 hours after the endoscopically guided application of sodium phosphate tablets (NaPT) and placebo tablets (PlaT) and were compared with unexposed sites. Different mucosal parameters were assessed with white light endoscopy, probe-based confocal laser endomicroscopy (pCLE), histology, and ex vivo permeability measurements.

Results: At 90 minutes after the application of NaPT, significant increases in epithelial irregularity and crypt pit intensity were observed with pCLE. These microscopic lesions persisted at 24 hours but were resolved at 72 hours. In addition, white light endoscopy revealed local exanthema in 57 % of the animals at 1.5 hours after NaPT application. Such lesions were observed in 22 % of the pigs at 24 hours and disappeared at 72 hours after application. After 1.5 hours, PlaT induced a slight but significant increase in epithelial irregularity, as well as architectural scores that were significantly lower than the ones induced by NaPT and that disappeared after 72 hours.

Conclusions: The direct and prolonged gastric application of NaPT in pigs can induce acute superficial macroscopic and microscopic injuries that are reversible within 72 hours.

• References

• 1 Millan MS, Gross P, Manilich E et al. Adenoma detection rate: the real indicator of quality in colonoscopy. Dis Colon Rectum 2008; 51: 1217-1220
• 2 Petersen BT. Quality measures and credentialing in gastrointestinal endoscopy. Curr Opin Gastroenterol 2010; 26: 459-465
• 3 Rex DK. Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc 2000; 51: 33-36
• 4 Sanchez W, Harewood GC, Petersen BT. Evaluation of polyp detection in relation to procedure time of screening or surveillance colonoscopy. Am J Gastroenterol 2004; 99: 1941-1945
• 5 Segnan N, Patnick S, von Karsa L et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Publications Office of the European Union; 2010
• 6 Wexner SD, Beck DE, Baron TH et al. A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc 2006; 63: 894-909
• 7 Chilton AP, O’Sullivan M, Cox MA et al. A blinded randomized comparison of a novel, low-dose, triple regimen with Fleet phospho-soda: a study of colon cleanliness, speed and success of colonoscopy. Endoscopy 2000; 32: 37-41
• 8 Kambe H, Yamaji Y, Sugimoto T et al. A randomized controlled trial of sodium phosphate tablets and polyethylene glycol solution for polyp detection. J Dig Dis 2012; 13: 374-380
• 9 Hassan C, Bretthauer M, Kaminski MF et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2013; 45: 142-150
• 10 Sacher-Huvelin S, Coron E, Gaudric M et al. Colon capsule endoscopy vs. colonoscopy in patients at average or increased risk of colorectal cancer. Aliment Pharmacol Ther 2010; 32: 1145-1153
• 11 Nam SY, Choi IJ, Park KW et al. Risk of hemorrhagic gastropathy associated with colonoscopy bowel preparation using oral sodium phosphate solution. Endoscopy 2010; 42: 109-113
• 12 Coton T, Luciano L, Marcelko A. Colic lesions induced by Colokit preparation. Clin Res Hepatol Gastroenterol 2011; 35: 509-510
• 13 Zwas FR, Cirillo NW, EI-Serag HB et al. Colonic mucosal abnormalities associated with oral sodium phosphate solution. Gastrointest Endosc 1996; 43: 463-466
• 14 Schir E, Barbouy-des-Courières S, Plottin F et al. [Colokit preparation (sodium phosphate) induced erosive gastritis]. Therapie 2012; 67: 477-479
• 15 Hagège H, Ponchon T, Laugier R et al. Etude des conditions d’utilisation et de la sécurité d’emploi d’un phosphate de sodium sous forme de comprimés, en France. Les Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive 2013; 173
• 16 Coskun A, Uzunkoy A, Duzgun SA et al. Experimental sodium phosphate and polyethylene glycol induce colonic tissue damage and oxidative stress. Br J Surg 2001; 88: 85-89
• 17 Li CQ, Xie XJ, Yu T et al. Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy. Am J Gastroenterol 2010; 105: 1391-1396
• 18 Fiorucci S, Santucci L, Gresele P et al. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Gastroenterology 2003; 124: 600-607
• 19 Batzri S, Harmon JW, Dubois A et al. A new in vivo method for repeatedly studying gastric acid secretion and other secretory parameters in awake guinea pig. J Surg Res 1987; 43: 398-406
• 20 Yeomans ND, Skeljo MV. Repair and healing of established gastric mucosal injury. J Clin Gastroenterol 1991; 13: 37-41